Diamandis Peter's Form 4 filing
Vaxxinity, Inc. (VAXX) · filed Nov 18, 2021
- Accession no.
- 0000899243-21-045293
- Filed
- Nov 18, 2021
- Trade date
- Nov 18, 2021
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. It was filed on the trade date.
This filing was later replaced by the amendment 0001437749-22-015774 (Jun 23, 2022). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Diamandis PeterCIK 0001528288 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 18, 2021 | Class A common stock | JOtherDisposed | −76,923 | $0.00 | $0 | 0 | Indirect | |
| Nov 18, 2021 | Class A common stock | JOtherAcquired | +76,923 | $0.00 | $0 | 76,923 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.